Pharvaris N.V.
PHVS
$14.28
-$0.34-2.33%
| Weiss Ratings | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Very Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.61 | |||
| Price History | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -8.29% | |||
| 30-Day Total Return | -9.62% | |||
| 60-Day Total Return | -22.98% | |||
| 90-Day Total Return | -35.94% | |||
| Year to Date Total Return | -22.98% | |||
| 1-Year Total Return | -36.70% | |||
| 2-Year Total Return | 61.90% | |||
| 3-Year Total Return | -23.21% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -44.00% | |||
| 52-Week Low % Change | 5.93% | |||
| Price | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $25.50 | |||
| 52-Week Low Price | $13.48 | |||
| 52-Week Low Price (Date) | Apr 04, 2025 | |||
| 52-Week High Price (Date) | May 02, 2024 | |||
| Valuation | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 774.45M | |||
| Enterprise Value | 434.19M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -2.81 | |||
| Earnings Per Share Growth | -12.87% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 2.34 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $14.28 | |||
| Enterprise Value/EBITDA (TTM) | -3.13 | |||
| Enterprise Value/EBIT | -3.13 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 54.07M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 31 71 203 6410 | |||
| Address | -- | |||
| Website | pharvaris.com | |||
| Country | Netherlands | |||
| Year Founded | 2015 | |||
| Profitability | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -32.80% | |||
| Return on Equity | -- | |||
| Income Statement | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -138.59M | |||
| EBIT (TTM) | -138.67M | |||
| Net Income (TTM) | -143.53M | |||
| Net Income Avl. to Common (TTM) | -143.53M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | -78.53% | |||
| EPS Diluted (TTM) | -2.81 | |||
| EPS Diluted Growth (Q YOY) | -35.09% | |||
| Balance Sheet | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 340.39M | |||
| Cash Per Share (Q) | $6.30 | |||
| Total Current Assets (Q) | 348.29M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 331.01M | |||
| Current Ratio (Q) | 19.075 | |||
| Book Value Per Share (Q) | $6.10 | |||
| Total Assets (Q) | 349.29M | |||
| Total Current Liabilities (Q) | 18.26M | |||
| Total Debt (Q) | 130.40K | |||
| Total Liabilities (Q) | 18.28M | |||
| Total Common Equity (Q) | 331.01M | |||
| Cash Flow | PHVS - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -443.90K | |||
| Cash from Financing (TTM) | 284.08M | |||
| Net Change in Cash (TTM) | 157.00M | |||
| Levered Free Cash Flow (TTM) | -68.12M | |||
| Cash from Operations (TTM) | -118.30M | |||
